Entactin is an integral component of basement membranes that plays a major role in basement membrane assembly through its ability to bind avidly to both laminin and type IV collagen. Because neutrophil (PMN) interactions with entactin have not been examined, we investigated the ability ofnatural and recombinant entactin to mediate PMN adhesion and chemotaxis. With both forms of entactin, we observed that entactin-coated surfaces promoted PMN adhesion and that entactin stimulated PMN chemotaxis. The increase in adhesion to entactin over control was two to threefold whereas the chemotactic response to 15 ng/ml (1 X 101 M) entactin was equivalent to the chemotactic response elicited with 1 x 10-8 M formyl-methionyl-leucyl-phenylalanine (fMLP). HL-60 cells, after differentiation with dimethylsulfoxide, also demonstrated adhesion and chemotaxis to entactin. A synthetic peptide of the Arg-GlyAsp (RGD) domain in entactin, SIGFRGDGQTC (S-RGD), mediated PMN adhesion and chemotaxis, and preexposure of PMN to S-RGD blocked PMN adhesion and chemotaxis induced by entactin without diminishing the adhesive and chemotactic activities of fMLP. In contrast, preexposure to peptides SIGFRGEGQTCA or SIGFKGDGQTCA had no effect. The findings with synthetic peptides were confirmed with a recombinant entactin mutant in which aspartic acid at residue 674 was replaced with glutamic acid, thus converting the RGD sequence of entactin to RGE. RGE-entactin was neither adhesive nor chemotactic for neutrophils. Monoclonal antibodies to the leukocyte response integrin (LRI) and the integrin-associated protein blocked entactin-mediated adhesion and chemotaxis whereas monoclonal antibodies to (8 and 12 integrins had no effect and PMN from an individual with leukocyte-adhesion deficiency adhered normally to entactin-coated surfaces. These data demonstrate that entactin mediates biologically and pathologically important functions of PMN through its RGD domain and that LRI, which has been shown previously to mediate RGD-stimulated phagocytosis, is also capable of mediating RGD-stimulated PMN adhesion and chemotaxis. (J. Clin. Invest. 1992Invest. .90:2251Invest. -2257
Acute inflammation is a complex response to local injury or infection ( 1 ) . The hallmark of acute inflammation is the rapid emigration of (PMNs) from the vasculature into the site of injury or infection. An early, critical event in the acute inflammatory response is adhesion of PMN to the endothelium at the site of inflammation. PMN-endothelial cell adhesion is mediated by specific plasma membrane molecules on both cell types and is markedly regulated by numerous protein and lipid factors specifically synthesized at sites of inflammation or infection (2, 3) . Because PMN-endothelial adhesion is necessary for the development of the host response, it has been the focus of intense investigation (4, 5) . Inhibitors of PMN adhesion to endothelium have shown a marked protective effect in experimentally induced acute inflammation in vivo (6) .
Less well defined have been the events subsequent to PMN-endothelial cell adhesion, involving diapedesis of PMN through the endothelial basement membrane into the underlying tissue. Recent studies suggest that emigrating PMN cause focal disruption of the basement membrane, however, the mechanisms for producing the defects are obscure since inhibitors of neutrophil proteinases and endoglycosidases are without effect (7) .
Previous investigations have shown that at least two components of the basement membrane, laminin and type IV collagen, stimulate PMN chemotaxis, adhesion, and enhanced phagocytosis of IgG opsonized targets (8) (9) (10) (11) (12) (13) (14) . Entactin is a more recently described basement membrane protein that binds to both type IV collagen and laminin and to cells (15) (16) (17) . Interactions between PMN and entactin have not been investigated. In the present report we demonstrate that entactin promotes PMN adhesion and chemotaxis and that both of these effects of entactin involve interactions between the ArgGly-Asp (RGD)' sequence in entactin with the leukocyte response integrin (LRI), a recently described integrin (10) .
Monoclonal antibodies to the f3I and f2 integrins do not diminish the adhesive or chemotactic activity of entactin, and PMN that lack 2 integrin expression adhere normally to entactincoated surfaces. These (18, 19) .
Entactin, SIGFRGDGQTC (S-RGD) and relatedpeptides, andformyl-methionyl-leucyl-phenylalanine (fMLP). Entactin was purified from M 1536-B3 extracellular matrix preparations (20) . Recombinant entactin was obtained from the baculovirus system previously described (21) . S-RGD was synthesized by Multiple Peptide Sys. (San Diego, CA). SIGFRGDGQTCA (S-RGD'), SIGFRGEGQTCA (S-RGE), and SIGFKGDGQTCA (S-KGD) were synthesized using 9-fluorenylmethyloxycarbonyl chemistry and the Ramps system (Dupont Co., Wilmington, DE) (22) . Peptides were purified by reverse phase HPLC after synthesis. Both S-RGD and S-RGD' were used in all experiments involving S-RGE or S-KGD and their effects were indistinguishable. fMLP was purchased from Sigma Chemical Co. (St. Louis, MO).
RGE-entactin mutant. The single RGD sequence of entactin is located at amino acid residues 672-674 (23) . An RGE-entactin mutant (RGE-entactin) was made in which the aspartic acid at residue 674 was replaced with glutamic acid (D-E). The mutagenic oligonucleotide was 5' AGT CGT CCC CTC TCC TCG GAA 3'. Site-directed mutagenesis was performed as described (24) (25) (26) . The bluescript cDNA clone E663 containing nucleotides 1,661-3,520 of the entactin sequence and which coded for the RGD peptide (23) was transformed into a dut-ung-Escherichia coli strain CJ236 (a gift from Dr. Duncan Groebe and also available from Bio-Rad Laboratories, Richmond, CA). The transformed CJ236 bacteria were grown in the presence ofan excess amount of uracil to generate uracil containing single-stranded DNA template. The exponentially growing bacteria were infected with the helper phage M 13K07 (Bio-Rad Laboratories) at MOI 20 to package the single-stranded phagemid DNA. After 1 h ofinfection, kanamycin was added to the culture medium and incubation continued overnight. The phage particles were collected by polyethylene glycol/ NaCl precipitation (27) . To check the level of uracil incorporation into the single-stranded DNA, the titer of the phage preparation was determined on both CJ236 (dut-ung ) and JM109 (dut+ ung+) by following previously described procedures (26 2.5 X 106 Spodopterafrugiperda cells (Sf9) (20) were cotransfected with 12 jig of a 1:5 mixture of baculovirus DNA and the mutant pAcEn. The procedures were as described by Tsao et al. (20) , except that for the transfection Lipofectin (Bethesda Research Laboratories) was used instead of calcium phosphate (28) . After 7 d of culture, the culture media were collected and screened for the recombinant virus (20, 28) . Briefly, Sf9 cells were seeded in 96-well microtiter plates and serially diluted virus was added to the wells. After 7 d ofculture, the media were saved and cells lysed and blotted onto nitrocellulose membrane using a dot blot apparatus (28) . The blots were then hybridized to a 32P-cDNA entactin probe. The media from positive clones were diluted and used for the next round of screening.
Sf9 monolayers were infected with culture medium containing recombinant virus and grown for 3 d. Cells were then harvested and rinsed briefly in PBS containing protease inhibitors. Cell pellets were resuspended in 0.25% Chaps in PBS, vortexed, and incubated on ice for 1 h. The mixture was centrifuged and the resulting pellet resuspended by vortexing in 6 M urea, 50 mM Tris (pH 7.4), 2 mM EDTA, and 2 mM DTT plus protease inhibitors. Entactin was extracted from the mixture by stirring overnight at 4VC. The insoluble materials were removed by centrifugation and the supernatant solution was collected and further purified by gel electrophoresis (20) . Silver stain of RGEentactin subjected to PAGE revealed a single band at 150 kD.
Antibodies. Monoclonal antibodies B6H 12, directed against the integrin-associated protein (IAP), and 7G2, directed against 33 integrins were prepared as previously described (10) . AlA5 and 4B4, anti-,B, beta-chain integrin monoclonal antibodies, were obtained from Dr. Martin Hemler, Dana-Farber Institute, Boston, MA and Coulter Corp., Hialeah, FL, respectively. Monoclonal antibody 1B4 directed against f2 integrins (29) was prepared as described (30) .
Chemotaxis assay. Chemotaxis was performed using modified Boyden chambers and a dual-filter system, consisting of 2-jim polycarbonate filters (Nuclepore, Pleasanton, CA) overlying 0.45-jm cellulose nitrate filters (Millipore Corp., Bedford, MA), as described previously ( 12) . After fixation and staining, the membrane pairs were evaluated by light microscopy, X400, for the number of cells that migrated through the upper membrane per high power grid (hpg) during a 40-min incubation. Each assay was run in triplicate. Positive controls consisted of fMLP at 1 x 1O-8 M in the lower compartment; negative controls consisted ofmedia only in the lower compartment. Results are reported as net cells, that is, cell counts corrected for the negative controls.
Adhesion assay. PMN adhesion was assayed in 72-well Terasaki plates (Nunc HLA plates 7651 1; Thomas Scientific, Swedesboro, NJ) using a modification of the procedure described by Wright et al. (31 ) .
Wells were filled with 5 Ail of PBS alone or 5 Ail of PBS with one of the following: 2.5 jig HSA, 25% (Armour Pharmaceutical Company, Kankakee, IL); fMLP, 1 X 10-8 M; entactin, 2.5 jg; S-RGD; 1 X 10-' M; or fibrinogen, 2.5 jig. The plates were incubated for 60 min at room temperature, washed with cold PBS, put on ice, and used immediately. PMN were suspended at 2 X 106 cells in Dulbecco's PBS containing human serum albumin, 0.5 mg/ml, 3 mM glucose and incubated for 15 min at 37°C. For studies involving either antibodies or PMN desensitization with entactin, S-RGD, S-RGE, or S-KGD, PMN were incubated for an additional 15 min at room temperature. 5 jl of PMN cell suspension was added to each well after which the plates were incubated for 30 min on ice and then for 30 min at 37°C. The plates were washed by dipping twice in PBS, covering with parafilm, inverting on a plate holder (PN 1 1065 carrier; Sorvall Instruments Div., Dupont Co., Newton, CT) and spinning at 600 rpm in a refrigerated centrifuge (RT 6000; Sorvall Instruments) for 1.5 min. The liquid in each well was removed by blotting and then glutaraldehyde, 2.5% (vol/vol), was added to each well for 30 min. The glutaraldehyde was removed and the wells washed twice with distilled water and left filled with distilled water. The adherent cells in each well were quantified by phase-contrast microscopy. Six wells were assayed for each parameter assessed.
Phagocytosis assay. The effect of entactin-derived peptides on fibrinogen-stimulated phagocytosis was determined by a fluid-phase assay as described ( 10, 32) . Sheep erythrocytes (E) were obtained from Whittaker Bioproducts (Walkersville, MD). Opsonized E (EIgG) were prepared as described using a 1:500 dilution of rabbit IgG anti-E (Diamedix Corp., Miami, FL). PMN were suspended in HBSS containing 4.2 mM NaHCO3, 10 mM Hepes, 1.5 mM MgCl2, 1.5 mM CaCl2, and 1% ovalbumin, pH 7.4. PMN ( 1.0 X I05) were incubated with 12.5 jsg of either entactin peptide, S-RGD, or a control peptide, peptide 32, in the presence of 5,000 U ofcatalase for 15 min at room temperature in a volume of 50 Al. Without washing, 50 A1 of either buffer or the indicated concentrations of human fibrinogen (American Diagnostica Inc., Greenwich, CT) diluted in buffer was added and the mixture was incubated with 15 Al of EIgG (5 X 107 E) for 30 min at 37°C. The noningested E were lysed with 0.83% (wt/vol) ammonium chloride. Phagocytosis was assessed by light microscopy and quantified as a phagocytic index, the number of EIgG ingested/ 100 PMN.
Results
Entactin mediates PMN adhesion and chemotaxis. Entactincoated surfaces promoted a two-to threefold increase in PMN adhesion compared with uncoated surfaces or surfaces coated with HSA ( Fig. 1 ) . Entactin from M 1 536-B3 extracellular matrix was indistinguishible from recombinant entactin (data not shown). Both recombinant and M 1 536-B3 entactins also stimulated neutrophil chemotaxis, with a peak response at a concentration of 15 ng/ml (1 X 10 -10 M) (Fig. 2) . The cell migration to either type of entactin preparation was equivalent to the chemotactic response elicited with the optimal chemotactic concentration offMLP, 1 x 10-8 M. "Checkerboard analysis" confirmed that PMN migration to entactin was a chemotactic response (Table I ). The directed migration to entactin was specific because preincubation of PMN with excess entactin blocked chemotaxis to entactin but not to fMLP.
Differentiated HL-60 cells show adhesion and chemotaxis to entactin. Native HL-60 cells did not exhibit adhesion or chemotaxis to entactin or fMLP, however, after incubation with DMSO for 72 h, they did demonstrate adhesion (Table II) to both ligands that was comparable to PMN, and they also responded chemotactically to both ligands. The chemotactic results with fM LP replicate observations of others ( 18) .
The RGD domain ofentactin mediates PMN adhesion and chemotaxis to entactin. Since S-RGD, which consists of RGD and flanking amino acids in entactin, partially blocks attachment of mouse mammary tumor cells to entactin-coated sur- faces (21 ), we speculated that the S-RGD domain of entactin might also be involved in PMN responses to entactin. As shown in Fig. 1 , PMN demonstrated enhanced adhesion to surfaces coated with S-RGD. This finding suggested that the adhesive properties of entactin for PMN might be mediated by the S-RGD domain of entactin. To test this possibility, and to look specifically at the role of the RGD sequence in S-RGD, PMN were preincubated with S-RGD, S-RGE, or S-KGD and then tested for adhesion to entactin. Controls for these observations were cells preincubated with entactin or S-RGD. As shown in Table III , preincubation with S-RGD blocked adhesion to entactin and S-RGD, but preincubation with either S-KGD or S-RGE had no effect on adhesion to entactin or S-RGD. Importantly, none of the preincubations had any effect upon the adhesiveness of the cells to fM LP.
Similar results were obtained in chemotaxis assays. S-RGD was chemotactic for PMN and preincubation of PMN with S-RGD blocked the chemotactic response to entactin, whereas preincubation with S-RGE had no effect (Fig. 3) . At concentrations that reduced chemotactic responsiveness to entactin, however, S-RGD had no effect upon the chemotactic responsiveness of the cells to fMLP, indicating that this peptide was not inducing a generalized loss of chemotactic responsiveness.
To further analyze the role of the RGD sequence in entactin in PMN adhesion and chemotaxis to entactin, the RGE-entactin was tested for PMN adhesion and chemotaxis. RGE-entactin did not produce an increase in adhesion over the control, in contrast to the findings described above with entactin purified from Ml 536-B3 extracellular matrix or recombinant entactin shown in Fig. 1 . Similarly, unlike entactin with the RGD sequence, RGE-entactin was not chemotactic (Fig. 4) . From the results ofthe adhesion and chemotaxis assays, we conclude that the RGD-containing domain of entactin has a major role in entactin-mediated PMN adhesion and chemotaxis.
Entactin-mediatedPMNadhesion andchemotaxis are independent ofthe integrin 1,1 and 12 families. Because the adhesive interaction between entactin and PMN was dependent on the RGD domain ofentactin, we reasoned that a member(s) ofthe integrin family of adhesive receptors was responsible (33) (34) (35) to fibrinogen-coated surfaces since this event requires 132 integrins (29) . Second, we examined the effect of the monoclonal antibody 1B4 on adhesion and chemotaxis to entactin and found that it had no effect.
The LRI and the IAP mediate PMN adhesion and chemotaxis to entactin. Recently, a novel integrnn has been shown to mediate RGD-stimulated phagocytosis( 10). This integrin, designated LRI, has not been assigned to an integrin family, but a monoclonal antibody to the beta chain of 13 integrins (7G2) inhibits the ability of LRI to amplify the phagocytic activity of RGD-stimulated PMN. We observed that 7G2 inhibited PMN adhesion (Fig. 5 ) and chemotaxis to entactin with minimal effect upon reducing PMN adhesion to fM LP. An isotype control antibody had no effect on adhesion or chemotaxis to entactin. To further examine the possible role of LRI in mediating entactin responses, we took advantage of the fact that LRI recognizes the RGD sequence within numerous proteins, includ- PBS  59±6  68±5  79±5  93±8  HSA  58±8  57±6  99±5  96±6   Fibrinogen  13±2  8±1  286±17  132±9  Entactin  181±12  71±7  281±15  99±5  S-RGD  156±17  65±7  229±8  85±10 Results are mean±SEM, n = 6. * Cells were preincubated with B6H 12, 10 jg/ml, for 15 min at room temperature.
ing fibrinogen, and that fibrinogen enhances PMN phagocytosis. Fibrinogen-stimulated ingestion is a well-established assay of LRI function ( 10) . Accordingly, we examined the ability of S-RGD to inhibit fibrinogen-stimulated phagocytosis of EIgG.
As shown in Fig. 6 , preincubation of PMN with S-RGD, but not with a control peptide, inhibited fibrinogen-stimulated ingestion.
Recently, a 50-kD plasma membrane molecule with the capacity to block RGD-stimulated phagocytosis has been identified on a wide variety ofcell types (22) . This protein has been labeled 1AP. Phagocytosis stimulated by RGD peptides, fibrinogen, and other RGD-containing ligands can be blocked by antibody to 1AP and by antibody to 133 integrins, suggesting that the function of 1AP is coordinated with 13 integrins. We found that B6H 12, an anti-IAP monoclonal antibody, inhibited PMN adhesion and chemotaxis mediated by entactin (Fig. 7) without reducing PMN adhesion and chemotaxis to fMLP. We also observed that B6H 12 abolished the adhesion of LAD PMN to entactin and S-RGD (Table IV) .
These data with 7G2 and B6H 12, together with the finding that S-RGD inhibits fibrinogen-stimulated phagocytosis, strongly suggest that LRI and IAP have a role in mediating 
Discussion
Basement membranes are complex structures composed principally oftype IV collagen, laminin, entactin, and heparan sulfate proteoglycans. Current concepts of basement membrane composition and structure have been presented in several recent reviews (37, 38) . Previously, two basement membrane components, laminin and type IV collagen, have been shown to display specific interactions with PMN (8, 9, (11) (12) (13) (14) . In the present studies we observed that entactin, an integral 1 50-kD sulfated glycoprotein basement membrane component that binds to type IV collagen and laminin and to several cell types ( 1 5-17), promotes PMN adhesion in the absence ofexogenous PMN stimulation and has potent chemotactic activity for PMN at subnanomolar concentrations. The use of recombinant entactin was an important feature of the present studies because it excluded the possibility that the results might reflect the effects of contaminating laminin or type IV collagen. We observed that the adhesive and chemotactic properties of entactin for PMN are associated with the single RGD domain in entactin (23) . A synthetic peptide that incorporates RGD and several of the amino acids that flank the RGD sequence present in entactin was able to mediate PMN adhesion and chemotaxis and could block the capacity of entactin to mediate these activities. Substitutions for individual amino acids in the RGD sequence of this peptide, such as RGE and KGD, drastically reduced the peptide's capacity to block the adhesive or chemotactic activity of entactin and therefore point specifically to the RGD sequence as critical. The importance of the RGD sequence in entactin, located at amino acid residues 672-674, in conferring adhesive and chemotactic activity was thoroughly established by studying RGE-entactin, a mutant entactin having glutamic acid substituted for aspartic acid at residue 674. Entactin having this single amino acid substitution did not display either adhesive or chemotactic activity for PMN. Accordingly, entactin appears to be a ligand in which recognition is based upon its RGD sequence, like fibronectin, fibrinogen, von Willebrand's factor, and vitronectin. It is noteworthy that the recombinant entactin derived from the baculovirus expression system is not glycosylated (20) Since the adhesive and chemotactic activities of entactin were mediated by RGD sequences, we tested whether integrins were involved in transducing these activities (33) (34) (35) B6H 12, an anti-IAP antibody, which also inhibits LRI function (22) , was as potent as 7G2 at inhibition ofPMN adhesion and chemotaxis to entactin. Finally, S-RGD inhibited fibrinogen-enhanced phagocytosis, a known function of LRI ( 10) . Thus, we postulate that entactin is a ligand for LRI. In addition, the present findings extend the known functions ofLRI to include signal transduction for adhesion and chemotaxis, as well as regulation of phagocytosis. It should be stressed, however, that these studies do not exclude the possibility that other PMN responses may be elicited by entactin and that these could be mediated by integrins other than LRI and also by nonintegrin receptors. Recent studies oflaminin receptors emphasize the extraordinary diversity of receptors that may be responsible for interactions between cells and a single extracellular matrix component (42) .
The adhesive activity of entactin for PMN is expressed by cells that have not been activated. Accordingly, interactions between PMN and entactin could serve as an important early event in the migration of PMN out of the vasculature. In this regard it is intriguing to note that entactin also causes release of a 92-kD metalloproteinase from PMN (R. Senior, unpublished observations). This metalloproteinase is contained in the specific granules of the PMN, a PMN compartment that is readily mobilized by a variety of signals (43, 44) . Since this proteinase has the capacity to degrade a number of extracellular matrix components, including type IV collagen, elastin, and proteoglycans (45, 46) , there is the interesting possibility that, in addition to mobilizing PMN, entactin also initiates processes that can lead to degradation of extracellular matrix. However, the situation in vivo in the context of an intact basement membrane may be much more complex since other basement membrane components may suppress neutrophil activation (47) .
Interactions between entactin and PMN have not been reported previously, but entactin has been shown to be adhesive for several cell types, including mouse mammary tumor cells, human melanoma cells, 3T3 cells, and osteosarcoma cells ( 17, 21 ) . In those studies, as in the present work with PMN, synthetic peptides incorporating the RGD sequence and several of the flanking amino acids in entactin displayed cell adhesive activity and competed with entactin for adhesion. Thus, PMNs are not the only cell type for which entactin has adhesive activity; however, it remains to be determined whether LRI and IAP are involved in mediating the effects ofentactin upon other cell types. Recent studies with human prostate carcinoma cells indicate that for this cell type the integrin a3#1 is the entactin receptor (48) .
Considering its presence in basement membranes, the adhesive and chemotactic properties of entactin may be important in acute inflammation. Moreover, recent studies demonstrating that entactin binds fibronectin (49) and fibrinogen (50) add further support for the possibility that entactin may interact with and thereby influence a variety of molecules known to be involved in inflammation and wound healing.
